ArticleCureus2026
Frequency of Hepatitis B and Hepatitis C Infections Among Patients With Chronic Kidney Disease: A Retrospective Data-Based Study From Lahore, Pakistan.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Chronic hepatitis B virus (HBV) and chronic hepatitis C virus (HCV) infections are significant global public health challenges, affecting millions of individuals worldwide and contributing substantially to morbidity and mortality due to chronic liver disease and its complications. In Pakistan, the burden of viral hepatitis remains considerable, with HBV and HCV infections continuing to affect vulnerable populations and placing an additional healthcare burden on patients with chronic diseases, including chronic kidney disease (CKD). This study aimed to determine the frequency of both HBV and HCV infections separately among CKD patients and to evaluate their relationship with demographic and clinical factors in a local Pakistani population. Methods This retrospective data-based study was conducted at Chaudhary Muhammad Akram Teaching and Research Hospital (Lahore, PAK) and included 317 medical records of CKD patients aged ≥18 years who presented to the Department of Medicine and Nephrology for dialysis and ICU admission from January to December 2025. Incomplete medical records, patients with acute kidney injury, and records missing hepatitis serologies were excluded. A structured pro forma was used to extract demographic characteristics, CKD-related variables, and laboratory parameters including HBsAg and anti-HCV antibodies from patient medical records. Data were analyzed using SPSS Statistics version 23 (IBM Corp., Armonk, NY, USA). Results Of the 317 CKD patients, 185 (58.4%) were male, and 184 (58.0%) resided in urban areas. Mean CKD duration was 2.9±2.8 years, with 185 (58.4%) having CKD for ≥2 years and 246 (77.6%) with stage 5 CKD. Hypertension was present in 271 (85.5%), diabetes in 171 (53.9%), and cardiovascular disease in 72 (22.7%). History of blood transfusion was reported in 140 (44.2%), while 214 (67.5%) had a history of dialysis. The mean hemoglobin (Hb) was 9.3±1.5 g/dL, with 247 (77.9%) having Hb>8 g/dL. Hepatitis B surface antigen (HBsAg) positivity was detected in 13 (4.1%) and anti-HCV in 131 (41.3%). Five (1.5%) had both HBsAg and anti-HCV positivity. Chi-square analysis revealed significantly associated anti-HCV positivity with the male gender (p<0.001), urban residence (p=0.038), CKD duration ≥2 years (p=0.027), advanced CKD stage (p<0.001), cardiovascular disease (p=0.049), blood transfusion history (p<0.001), and dialysis history (p<0.001). Binary logistic regression analysis demonstrated male gender (OR=0.483, 95% CI: 0.277-0.839; p=0.010), urban residence (OR=0.520, 95% CI: 0.305-0.887; p=0.016), positive history of blood transfusion (OR=0.348, 95% CI: 0.183-0.660; p=0.001), and dialysis history (OR=0.211, 95% CI: 0.091-0.488; p<0.001) to be predictors of anti-HCV positivity. Fisher's exact test demonstrated a significant association of HBsAg with the female gender (p
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.